Proteome Sciences Signs Contract with Takeda for Protein Biomarker Research
April 01, 2011
Proteome Sciences Signs Contract with Takeda for Protein Biomarker Research
Under the deal, which follows on a similar 2009 agreement between the firms, Proteome Sciences will provide Takeda with mass spec-based assays for the discovery and validation of protein biomarkers tied to various undisclosed diseases.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Proteome Sciences Inks Deal with Eisai for First Commercial Use of Alzheimer's Biomarker Panel
February 4, 2011 / ProteoMonitor - Evotec to Use PhosphoScout Platform in Oncology Biomarker Alliance with Roche
July 1, 2011 / ProteoMonitor - Protein Biomarkers for Alzheimer's Predicted to Represent Cumulative $9B Market Over Next Decade
June 3, 2011 / ProteoMonitor - Proteome Sciences and Icon Collaborate on Mass Spec Assays for Pharma Biomarker Development
November 19, 2010 / ProteoMonitor - Proteome Sciences Inks Deal to Provide Siena Biotech with Protein Biomarker Services
August 12, 2011 / ProteoMonitor